惠普森医药(CPHI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CPHI 惠普森医药

交易中 04-15 13:45:50 EDT

0.6198

+0.0023

+0.37%

最高0.6497	最低0.6198	成交量5,216
今开0.6497	昨收0.6175	日振幅4.84%
总市值2,512万	流通市值145.07万	总股本4,052万
成交额3,305	换手率0.22%	流通股本234.06万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CPHI","market":"US","secType":"STK","nameCN":"惠普森医药","latestPrice":0.6198,"timestamp":1776275115856,"preClose":0.6175,"halted":0,"volume":5216,"delay":0,"changeRate":0.003724696356275253,"floatShares":2340600,"shares":40522002,"eps":-0.742772,"marketStatus":"交易中","change":0.0023,"latestTime":"04-15 13:45:50 EDT","open":0.6497,"high":0.6497,"low":0.6198,"amount":3305.21979904,"amplitude":0.048421,"askPrice":0.659,"askSize":100,"bidPrice":0.5905,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-0.742772,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1776283200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1254283200000,"exchange":"AMEX","adjPreClose":0.6175,"postHourTrading":{"tag":"盘后","latestPrice":0.6175,"preClose":0.6175,"latestTime":"17:59 EDT","volume":2,"amount":1.2473,"timestamp":1776203999511,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.415065},"requestUrl":"/m/hq/s/CPHI","defaultTab":"news","newsList":[{"id":"1124489309","title":"惠普森医药：据SEC文件披露，预计2025财年营收成本、毛损及净损较2024财年将现显著变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1124489309","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124489309?lang=zh_cn&edition=full","pubTime":"2026-04-02 04:16","pubTimestamp":1775074585,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会（SEC）的文件显示，惠普森医药（China Pharma Holdings, Inc.）对其2025财年的财务表现作出重要预测。公司预计，在2025财年，其营收成本、毛损以及净损等项目，相较于2024财年同期数据，将发生显著变化。\n此番预期突显出该公司在接下来财年可能面临的财务挑战与运营调整。具体变动幅度及背后驱动因素，投资者需密切关注公司后续发布的详细财务报告及管理层讨论与分析。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CPHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609348881","title":"美股异动丨博美集团跌38.08%，为跌幅最大的中概股","url":"https://stock-news.laohu8.com/highlight/detail?id=2609348881","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609348881?lang=zh_cn&edition=full","pubTime":"2026-02-05 09:07","pubTimestamp":1770253622,"startTime":"0","endTime":"0","summary":"中概股收盘跌幅居前的个股为：博美集团跌38.08%，联代科技跌33.65%，华谌科技跌21.29%，惠普森医药跌19.99%，MKDWELL Tech跌17.93%。(格隆汇)","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202602/05/20260205720572.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202602/05/20260205720572.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260205/31999916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4535","MNQmain","BK4585","DRAG","BGM","BK4550","BK4007","ASHR","TNA","BK4588","SRTY","BK4614","TWM","CHAU","ASHS","BK4581","UWM","BK4534","CQQQ","FXI","CWEB","IWO","MCHI","CPHI","RWM","IWN","TZA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139961131","title":"惠普森医药：根据协议，Juan Zhang将把Ipragliflozin片剂及其制备方法的所有权转让给公司旗下子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1139961131","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139961131?lang=zh_cn&edition=full","pubTime":"2025-12-24 05:25","pubTimestamp":1766525134,"startTime":"0","endTime":"0","summary":"惠普森医药：根据协议，Juan Zhang将把Ipragliflozin片剂及其制备方法的所有权转让给公司旗下子公司","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CPHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504172423","title":"奥赛康药业1类新药利厄替尼片获批上市；强生146亿美元收购Intra-Cellular | CPHI制药在线一周药闻复盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2504172423","media":"CPHI制药在线","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504172423?lang=zh_cn&edition=full","pubTime":"2025-01-18 19:31","pubTimestamp":1737199882,"startTime":"0","endTime":"0","summary":"首先看审评审批方面，多个药获批，很值得一提的就是，奥赛康药业1类新药利厄替尼片获批上市；其次是研发方面，多个药取得重要进展，其中，全球第2款PROTAC药物BMS-986365进入Ⅲ期阶段；最后是交易及投融资方面，有不少交易尘埃落定，最大金额的是，强生146亿美元收购Intra-Cellular。该药物是首个获准用于一线治疗MCL的BTK抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118193422a226a6a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118193422a226a6a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1059921491.USD","IE00B7SZLL34.SGD","LU1261432733.SGD","CPHI","LU2347655156.SGD","LU1935042991.SGD","BK4592","IE00B19Z3B42.SGD","IE00B2B36J28.USD","LU0203345920.USD","LU1894683348.USD","SG9999002224.SGD","IE00B1BXHZ80.USD","LU0640476718.USD","LU1244550577.SGD","IE00B42XCP33.USD","LU0792757196.USD","LU0098860793.USD","LU0345770308.USD","IE00BFTCPJ56.SGD","IE00BGHQF631.EUR","LU1221951129.SGD","LU1506573853.SGD","LU1674673691.USD","IE000M9KFDE8.USD","LU1914381329.SGD","IE00B4R5TH58.HKD","IE0002270589.USD","IE00BJT1NW94.SGD","LU1585245621.USD","LU0795875169.SGD","JNJ","IE00BVYPNW00.USD","LU2602419157.SGD","SG9999002232.USD","LU0122379950.USD","IE00BSNM7G36.USD","LU1221951046.USD","LU1066051225.USD","LU1929549753.HKD","LU1066051498.USD","IE00B19Z3581.USD","LU0889566641.SGD","IE00BJJMRZ35.SGD","LU1061106388.HKD","BK4559","BK4533","LU0289739699.SGD","IE0009355771.USD","LU1430594728.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2475371522","title":"科兴制药亮相CPHI Milan 2024 白蛋白紫杉醇欧盟发布仪式成功举办","url":"https://stock-news.laohu8.com/highlight/detail?id=2475371522","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475371522?lang=zh_cn&edition=full","pubTime":"2024-10-15 10:38","pubTimestamp":1728959883,"startTime":"0","endTime":"0","summary":"10月10日，全球规模较大、影响力较强的医药行业盛会——2024世界制药原料欧洲展在意大利米兰国际展览中心圆满落幕。值得一提的是，科兴制药在展会期间举办了白蛋白紫杉醇欧盟上市发布仪式，与海昶生物、欧洲市场的合作伙伴共同见证这里程碑式的一刻。据悉，该产品于今年5月获得欧盟药品GMP证书，7月底获得欧盟上市批准，并已于8月开始陆续发货。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=7BVoVRq0mso%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","688136","BK0239","CPHI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinapharmaholdings.com","stockEarnings":[{"period":"1week","weight":-0.0276},{"period":"1month","weight":0.0252},{"period":"3month","weight":-0.506},{"period":"6month","weight":-0.6715},{"period":"1year","weight":-0.5589},{"period":"ytd","weight":-0.4897}],"compareEarnings":[{"period":"1week","weight":0.0535},{"period":"1month","weight":0.0486},{"period":"3month","weight":0.0059},{"period":"6month","weight":0.0512},{"period":"1year","weight":0.2881},{"period":"ytd","weight":0.0184}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"中国医药控股有限公司成立于1999年1月28日。通过其全资子公司海南合盛医疗生物技术有限公司及其在中国的子公司，该公司从事用于人体的药品的开发、生产和营销。其产品组合包括基础仿制药、首仿药和现代中药。","yearOnYearQuotes":[{"month":1,"riseRate":0.470588,"avgChangeRate":0.14812},{"month":2,"riseRate":0.588235,"avgChangeRate":0.024723},{"month":3,"riseRate":0.411765,"avgChangeRate":-0.035858},{"month":4,"riseRate":0.294118,"avgChangeRate":-0.06263},{"month":5,"riseRate":0.125,"avgChangeRate":-0.124434},{"month":6,"riseRate":0.5,"avgChangeRate":0.045299},{"month":7,"riseRate":0.3125,"avgChangeRate":-0.053581},{"month":8,"riseRate":0.125,"avgChangeRate":-0.112317},{"month":9,"riseRate":0.25,"avgChangeRate":-0.057874},{"month":10,"riseRate":0.529412,"avgChangeRate":0.027245},{"month":11,"riseRate":0.352941,"avgChangeRate":-0.000653},{"month":12,"riseRate":0.470588,"avgChangeRate":-0.03917}],"exchange":"AMEX","name":"惠普森医药","nameEN":"China Pharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.41.0","shortVersion":"4.41.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"惠普森医药(CPHI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供惠普森医药(CPHI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"惠普森医药,CPHI,惠普森医药股票,惠普森医药股票老虎,惠普森医药股票老虎国际,惠普森医药行情,惠普森医药股票行情,惠普森医药股价,惠普森医药股市,惠普森医药股票价格,惠普森医药股票交易,惠普森医药股票购买,惠普森医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"惠普森医药(CPHI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供惠普森医药(CPHI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}